Показано 0 из 0
Дата |
---|
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
18.04.2024 |
17.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
|
|
2.015
|
2.015
|
2.055
|
2.055
|
|
|
|
|
|
|
1.91
|
1.91
|
1.998
|
1.998
|
|
|
|
|
|
|
1.862
|
1.862
|
1.862
|
1.862
|
|
|
|
|
|
|
1.864
|
1.84
|
1.864
|
1.856
|
|
|
|
|
|
|
1.882
|
1.844
|
1.882
|
1.844
|
|
|
|
|
|
|
1.834
|
1.814
|
1.86
|
1.86
|
|
|
|
|
|
|
1.864
|
1.864
|
1.864
|
1.864
|
|
|
|
|
|
|
1.96
|
1.824
|
1.96
|
1.86
|
|
|
|
|
|
|
1.668
|
1.668
|
1.964
|
1.964
|
|
|
|
|
|
|
1.544
|
1.544
|
1.554
|
1.554
|
|
|
|
|
Acurx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on developing a new class of antibiotics for infections caused by bacteria. Acurx Pharmaceuticals serves customers worldwide.